BMO Hosts First Obesity Summit on Future of Obesity Care Market

Rhea-AI Summary

BMO to host inaugural Obesity Summit in New York City to discuss trends in obesity treatment and medical weight-management therapeutics. The conference will feature panels and presentations on various topics, including the emerging therapeutic landscape, patient perspectives, care delivery, metabolic research, and coverage and access.

• Healthcare industry experts and leaders will convene at inaugural BMO Obesity Summit to examine outlook and trends in obesity treatment

NEW YORK, March 13, 2024 /PRNewswire/ - BMO will host its first Obesity Summit on March 20, 2024 in New York City. The conference will target buy-side investors who want to hear from leading biotech and pharmaceutical companies developing medical weight-management therapeutics and stakeholders across the continuum of care and delivery. Topics straight from the headlines will be discussed via panels and presentations, including:

• A panel on the emerging therapeutic landscape
• The Patient's Voice: a conversation with patients on GLP-1+ therapy
• Obesity 101 with Intellihealth, featuring Dr Katherine Saunders
• Care delivery featuring Beth Israel Lahey Health, Weight Watchers, and Intellihealth
• A key opinion leader's insights on metabolic research, featuring Weill Cornell Medical College's Dr Louis J. Aronne
• A payors panel addressing coverage and access, featuring Prime Therapeutics

"Important conversations need to happen around the development and delivery of obesity care," said Evan Seigerman, Senior Biotechnology & Pharmaceuticals Analyst, BMO. "This summit is about having those discussions and sharing ideas and solutions from thought leaders and experts who can move the dial to meet challenges to deliver care for patients with obesity and metabolic disease."

BMO analysts, including Evan Seigerman, will host discussions with leading life sciences companies, including:

• Altimmune
• Amgen
• Capital Rx
• Corbus Pharmaceuticals
• Eli Lilly & Co.
• Novo Nordisk
• Intellihealth
• Prime Therapeutics
• Scholar Rock
• Structure Therapeutics
• Terns Pharmaceuticals
• Weight Watchers

For more information or to request an interview with one of BMO's equity research analysts, please contact BMO Media Relations using the contact details below. Note: There are restrictions for media on access to presentations and certain speakers.

About BMO Financial Group

BMO Financial Group is the eighth largest bank in North America by assets, with total assets of $1.3 trillion as of January 31, 2024. Serving customers for 200 years and counting, BMO is a diverse team of highly engaged employees providing a broad range of personal and commercial banking, wealth management, global markets and investment banking products and services to 13 million customers across Canada, the United States, and in select markets globally. Driven by a single purpose, to Boldly Grow the Good in business and life, BMO is committed to driving positive change in the world, and making progress for a thriving economy, sustainable future, and inclusive society.

View original content:https://www.prnewswire.com/news-releases/bmo-hosts-first-obesity-summit-on-future-of-obesity-care-market-302088442.html

SOURCE BMO Financial Group

FAQ

When and where will the BMO Obesity Summit take place?

The BMO Obesity Summit will be held on March 20, 2024, in New York City.

Who is the target audience for the summit?

The conference will target buy-side investors and stakeholders involved in the development and delivery of medical weight-management therapeutics.

What topics will be discussed at the summit?

The summit will cover various topics, including the emerging therapeutic landscape, patient perspectives on GLP-1+ therapy, care delivery, metabolic research, and coverage and access.

Who are some of the featured speakers at the summit?

Speakers at the summit include Dr. Katherine Saunders from Intellihealth, Beth Israel Lahey Health, Weight Watchers, Dr. Louis J. Aronne from Weill Cornell Medical College, and Prime Therapeutics.

Why is the summit important?

The summit aims to facilitate important conversations around the development and delivery of obesity care, addressing key issues in the industry.